Acute Myeloid Leukemia Clinical Trial

Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia

Summary

This trial studies the feasibility of delivering the Partners in Care Program to caregivers of patients with acute myeloid leukemia. Psychological counseling interventions, such as the Partners in Care Program, may help to improve caregivers' psychosocial functioning, marital adjustment in the context of the cancer, communication, and support skills to the patient.

View Full Description

Full Description

OUTLINE: Participants are randomized to 1 of 2 groups.

GROUP A: Participants attend 5 psychoeducational counseling sessions over 30-60 minutes via telephone.

GROUP B: Participants attend 5 psychoeducational counseling sessions over 30-60 minutes via video teleconference.

After completion of study, participants are followed up at 4 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of AML within the recent 2 months
Caregivers and patients need to write, read, and speak English as one of their languages of choice; and currently sharing a residence at least 50% of the time together
Patient must have no other concurrent cancer diagnosis except for basal or squamous cell
Caregiver must be able to sustain up to 60 minutes of interaction with patient educator
Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

Participants will be excluded if either the patient or the caregiver cannot write, read, and speak English as one of their languages of choice; are not currently sharing a residence at least 50% of the time together
The patient cannot have another concurrent cancer diagnosis except for basal or squamous cell
Caregiver cannot sustain up to 60 minutes of interaction with the patient educator
Caregiver does not have access to a computer with 2-way video capability (i.e. ZOOM) or a cell phone

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

12

Study ID:

NCT03806192

Recruitment Status:

Terminated

Sponsor:

University of Washington

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Fred Hutch/University of Washington Cancer Consortium
Seattle Washington, 98109, United States

How clear is this clinincal trial information?

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

12

Study ID:

NCT03806192

Recruitment Status:

Terminated

Sponsor:


University of Washington

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider